The aim of this project is to characterize MDS-specific or oncospecifc protein isoforms (OPIs), originating from alternative splicing, as potential targets for treatment in MDS patients using a multi-omics (DNA, RNA and proteins) approach. We will focus our investigation on MDS-specific structural and functional OPIs as potential targets for i) immune mediated treatment or ii) pharmacological inhibition of enzymatic functions.